so a regulatory lawyer and a first amendment scholar walk into a bar…
read up on the intersection of speech and regulatory law. the post discusses ‘off-label use’ of prescription drugs and the FDA’s regulations on how doctors and drug companies can talk about those uses.
Advertisement
